Greenberg D P, Ward J I, Bayer A S
Department of Pediatrics, University of California at Los Angeles School of Medicine, Harbor-UCLA Medical Center, Torrance 90502.
Infect Immun. 1987 Dec;55(12):3030-4. doi: 10.1128/iai.55.12.3030-3034.1987.
To evaluate the potential protective benefit of antibody to whole cells of Staphylococcal aureus for the prevention of endocarditis, the rabbit endocarditis model was used. Methicillin-sensitive (17A) and methicillin-resistant (173) S. aureus strains were evaluated in rabbits with or without indwelling intracardiac catheters. All immunized rabbits developed significant homologous agglutinating antibody titers (the mean reciprocal titers were 15,300 to strain 17A and 1,150 to strain 173). After challenge, virtually no significant differences were observed between immunized and unimmunized animals with respect to (i) incidence of endocarditis, (ii) concentration of bacteria in infected vegetations, (iii) incidence of metastatic renal abscesses, or (iv) concentrations of bacteria in infected kidneys. The clearance of homologous S. aureus strains from blood cultures was similar for immunized and unimmunized animals at 10 to 90 min after intravenous challenge. In vivo adherence of homologous S. aureus strains to aortic valves and vegetations was similar in immunized and unimmunized animals when evaluated at 30 and 90 min postchallenge. Even without catheterization, the incidence of bacteremia and renal abscesses was the same in immunized and unimmunized rabbits. Whole-cell-induced S. aureus antibody did not prevent or modify any stage in the development of endocarditis in rabbits.
为评估抗金黄色葡萄球菌全细胞抗体对预防心内膜炎的潜在保护作用,采用了兔心内膜炎模型。在有或无心脏内留置导管的兔子中评估了甲氧西林敏感(17A)和耐甲氧西林(173)金黄色葡萄球菌菌株。所有免疫兔子均产生了显著的同源凝集抗体效价(对17A菌株的平均倒数效价为15300,对173菌株为1150)。在进行攻击后,在以下方面未观察到免疫动物和未免疫动物之间存在显著差异:(i)心内膜炎的发生率,(ii)感染赘生物中的细菌浓度,(iii)转移性肾脓肿的发生率,或(iv)感染肾脏中的细菌浓度。在静脉注射攻击后10至90分钟,免疫动物和未免疫动物从血培养物中清除同源金黄色葡萄球菌菌株的情况相似。在攻击后30分钟和90分钟评估时,免疫动物和未免疫动物中同源金黄色葡萄球菌菌株对主动脉瓣和赘生物的体内黏附情况相似。即使不进行导管插入术,免疫兔子和未免疫兔子的菌血症和肾脓肿发生率也相同。全细胞诱导的金黄色葡萄球菌抗体不能预防或改变兔子心内膜炎发展的任何阶段。